GSK plc (G1SK34)
B3 Stock Exchange · Brazil · prices in BRL · close of 26 Oct 2026
Key indicators
| Last close | BRL 55.30 |
|---|---|
| 52-week range | 46.15 – 63.24 |
| Return, 1 month / 3 months | +8.2% / +8.3% |
| Return, 1 year / 3 years | +20.1% / +73.3% |
| Trend | Uptrend |
| RSI (14) | 72 |
| Volatility (1 year) | 29.1% |
| Worst drawdown (1 year) | -24.5% |
| Average daily value traded | 0.02M BRL |
| Dividend yield | 21.4% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
GSK plc is a pharmaceutical company based in the United Kingdom that researches, develops and makes prescription medicines and vaccines. Its products address respiratory conditions, infections, HIV, cancer and other illnesses, and it supplies healthcare providers, hospitals and governments around the world. The company also produces consumer healthcare brands for everyday ailments, sold through pharmacies and retailers. GSK operates research and manufacturing sites internationally and serves patients in many countries through its medicines and vaccine portfolio.
GSK plc is represented on the B3 Stock Exchange in Brazil by a Brazilian depositary receipt (BDR) under the code G1SK34, with its price quoted in Brazilian reais (BRL). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
GSK plc (G1SK34) trades on the B3 Stock Exchange in Brazil. It last closed at BRL 55.30 on 26 October 2026.
Its price-based Market X-Ray is 55 out of 100 (a fair price profile), ranking 567 of 1,455 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 20.1% and over the last three months it rose 8.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on B3 Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 47 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | 4.6% | ||
| From 52-week high | -11.8% | ||
| Momentum | 55 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 8.3% | ||
| 6-month return | 1.1% | ||
| 12-month return, skipping the last month | 11.0% | ||
| Stability (higher is calmer) | 69 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 29.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -24.5% | ||
| Liquidity | 28 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.02M BRL | ||
| Zero-volume days | 36.7% | ||
| Income | 85 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 21.4% | ||
| Years with dividends | 6 |
Strengths
- Income: Dividend is high and has been paid regularly.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +10.2% |
|---|---|
| 1 month | +8.2% |
| 3 months | +8.3% |
| 6 months | +1.1% |
| 1 year | +20.1% |
| 3 years | +73.3% |
| 5 years | +26.2% |
Signals
| 50-day / 200-day average | 50.54 / 52.87 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.04 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 12 Aug 2026 | GBP 0.4392 |
| 13 May 2026 | GBP 0.4409 |
| 18 Feb 2026 | GBP 0.4563 |
| 12 Nov 2025 | GBP 0.4422 |
| 13 Aug 2025 | GBP 0.4445 |
| 14 May 2025 | GBP 0.4601 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on B3 Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.